LUPRON DEPOT
LUPRON DEPOT
Approved
DIN Number
02239833
Drug Class
Human
Market Date
Sep 13, 1999
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02239833
AIG Number0116959007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02AE02 LEUPRORELIN
Product Specifications
Dosage FormPowder For Suspension, Sustained-Release
Route of AdministrationIntramuscular
AHFS Classification68:18.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
LEUPROLIDE ACETATEActive
Strength: 30 MG / SYR
Monograph: LEUPROLIDE ACETATE